ea0095p137 | Obesity 2 | BSPED2023
Mcquillan Erin
, Dunne J
, Horrocks I
, Mochrie R
, Joseph S
, Shepherd S
, Wong SC
Background: Glucocorticoid (GC) therapy is the standard management for Duchenne Muscular Dystrophy (DMD), but its use is associated with significant side effects, including weight gain. Limited research exists on the impact of GC initiation on body composition in DMD, particularly regarding the timing of fat mass increase.Objective: This study aimed to assess changes in growth parameters, namely height-SDS, weight-SDS, b...